148 related articles for article (PubMed ID: 19672972)
21. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.
Martino A; Campa D; Buda G; Sainz J; García-Sanz R; Jamroziak K; Reis RM; Weinhold N; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Szemraj J; Stein A; Kumar R; Orciuolo E; Gemignani F; Landi S; Goldschmidt H; Petrini M; Dumontet C; Canzian F; Rossi AM
Leukemia; 2012 Jun; 26(6):1419-22. PubMed ID: 22182917
[No Abstract] [Full Text] [Related]
22. Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival.
Suvannasankha A; Minderman H; O'Loughlin KL; Nakanishi T; Ford LA; Greco WR; Wetzler M; Ross DD; Baer MR
Br J Haematol; 2004 Nov; 127(4):392-8. PubMed ID: 15521915
[TBL] [Abstract][Full Text] [Related]
23. Drug resistance associated properties of blasts subpopulations with different CD34 expression in childhood acute lymphoblastic leukemia (ALL).
Shman TV; Fedasenka UU; Savitski VP; Kustanovich AM; Aleinikova OV
Exp Oncol; 2011 Sep; 33(3):145-9. PubMed ID: 21956467
[TBL] [Abstract][Full Text] [Related]
24. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.
van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P
Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137
[TBL] [Abstract][Full Text] [Related]
25. Role of chemotherapy resistance genes in outcome of neuroblastoma.
de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of multidrug resistance in 46 newly diagnosed patients with acute leukemia.
de Moraes AC; Licínio MA; Zampirolo JA; Liedke SC; Del Moral JA; Machado MJ; Bazzo ML; da Silva MC
Hematology; 2012 Mar; 17(2):59-65. PubMed ID: 22664042
[TBL] [Abstract][Full Text] [Related]
27. Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.
Erdilyi DJ; Kámory E; Csókay B; Andrikovics H; Tordai A; Kiss C; Filni-Semsei A; Janszky I; Zalka A; Fekete G; Falus A; Kovács GT; Szalai C
Pharmacogenomics J; 2008 Oct; 8(5):321-7. PubMed ID: 17938643
[TBL] [Abstract][Full Text] [Related]
28. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia.
Erdélyi DJ; Kámory E; Zalka A; Semsei AF; Csókay B; Andrikovics H; Tordai A; Borgulya G; Magyarosy E; Galántai I; Fekete G; Falus A; Szalai C; Kovács GT
Cell Immunol; 2006 Dec; 244(2):121-4. PubMed ID: 17434155
[TBL] [Abstract][Full Text] [Related]
29. Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer.
Tsyganov MM; Freidin MB; Ibragimova MK; Deryusheva IV; Kazantseva PV; Slonimskaya EM; Cherdyntseva NV; Litviakov NV
Cancer Chemother Pharmacol; 2017 Aug; 80(2):251-260. PubMed ID: 28601971
[TBL] [Abstract][Full Text] [Related]
30. Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells.
Issa ME; Hall SR; Dupuis SN; Graham CL; Jakeman DL; Goralski KB
Anticancer Drugs; 2014 Mar; 25(3):255-69. PubMed ID: 24231527
[TBL] [Abstract][Full Text] [Related]
31. The role of breast cancer resistance protein in acute lymphoblastic leukemia.
Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG
Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996
[TBL] [Abstract][Full Text] [Related]
32. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma.
Drain S; Flannely L; Drake MB; Kettle P; Orr N; Bjourson AJ; Catherwood MA; Alexander HD
Leuk Res; 2011 Nov; 35(11):1457-63. PubMed ID: 21705081
[TBL] [Abstract][Full Text] [Related]
34. Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia.
Sauerbrey A; Voigt A; Wittig S; Häfer R; Zintl F
Leuk Lymphoma; 2002 Apr; 43(4):875-9. PubMed ID: 12153178
[TBL] [Abstract][Full Text] [Related]
35. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
36. Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India.
Gurbuxani S; Zhou D; Simonin G; Raina V; Arya LS; Sazawal S; Marie JP; Bhargava M
Ann Hematol; 1998 May; 76(5):195-200. PubMed ID: 9671132
[TBL] [Abstract][Full Text] [Related]
37. Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.
Cihalova D; Ceckova M; Kucera R; Klimes J; Staud F
Biochem Pharmacol; 2015 Dec; 98(3):465-72. PubMed ID: 26300056
[TBL] [Abstract][Full Text] [Related]
38. Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response.
Litviakov NV; Cherdyntseva NV; Tsyganov MM; Denisov EV; Garbukov EY; Merzliakova MK; Volkomorov VV; Vtorushin SV; Zavyalova MV; Slonimskaya EM; Perelmuter VM
Cancer Chemother Pharmacol; 2013 Jan; 71(1):153-63. PubMed ID: 23053273
[TBL] [Abstract][Full Text] [Related]
39. [Expression of ATP-binding cassette transporter genes in nasopharyngeal carcinoma].
DU SS; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):449-52. PubMed ID: 18359711
[TBL] [Abstract][Full Text] [Related]
40. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
